molecules of the month


pan-genotype, pan-serotype dengue virus inh.

high barrier to resistance, efficacious in vivo

from phenotypic antiviral screen


Janssen Pharmaceutica, Beerse, BE

Chemical structure of molecule JNJ-A07
1 min read

The Janssen pan-genotype, pan-serotype dengue virus inhibitor, JNJ-A07, demonstrates broad activity against a panel of 21 clinical isolates and has a high barrier to resistance. It blocks the interaction between the non-enzymatic NS4B protein and NS3, preventing them from forming an NS3-NS4B complex which is essential for replication (though it does not appear to dissociate formed NS3-NS4B complexes). The mechanism is another recent success for phenotypic screening and if developed, this class of molecules could be a significant tool against dengue disease, which affects >96M individuals worldwide.

request a trial

You don’t have time to read everything, but you can’t afford to fall behind.

Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.

Get ahead now by requesting a trial.

already a member? log in: